Background/Objectives: Heart failure (HF) poses a significant global health burden. In Spain, its prevalence rises annually, contributing significantly to cardiovascular-related hospitalizations and deaths. Through a broad and integrative perspective, the CARABELA-HF initiative seeks to improve the organization and delivery of HF care in Spain, addressing the key challenges identified across the care continuum. Methods: CARABELA-HF involved four phases: characterization of HF care models, validation of improvement areas, potential solutions and healthcare quality indicators, refinement of results from a regional perspective, and local dissemination and implementation. Ten pilot centers participated, and nine variables were identified to characterize operating HF care models. Results: Four HF care models were identified based on the degree of coordination between departments and resource availability. Structure, quality of care, and transformation indicators were used to evaluate these models, revealing improvement areas. Overall, this process identified solutions for generating a comprehensive and integrated HF care model, highlighting enhanced coordination, digital transformation, enhanced nursing roles, professional training and patients’ education, accredited HF care models, resource accessibility, and data-based evaluation. Conclusions: CARABELA-HF provides insights into current HF care models in Spain and identifies healthcare quality indicators for future improvement efforts. It strives to enhance patient outcomes, raise healthcare standards, and improve overall system efficiency through the promotion of a comprehensive and integrated HF care pathway.
Background: Transthyretin amyloidosis (ATTR) is a multisystem, progressive, and potentially fatal condition. It is significantly under-recognized, leading to delayed diagnosis and treatment and poor outcomes. The CARABELA-ATTR initiative aims to address the challenges of ATTR management in the Spanish healthcare system. Methods: This initiative promotes collaboration between scientific societies, clinicians, and the pharmaceutical industry to optimize ATTR care using lean methodology. It included four phases: (1) characterization of ATTR clinical pathways; (2) validation and prioritization of areas for improvement and selection of quality indicators (QIs); (3) co-creation of solutions; and (4) dissemination of results. Results: A generic ATTR patient journey was defined, identifying four healthcare models with varying coordination and resources. Multidisciplinary discussions identified 13 areas for improvement, including deficient multidisciplinary coordination, lack of standardized diagnostic protocols, and uneven resource distribution. A set of QIs covering all aspects of care was defined. Validated solutions included establishing multidisciplinary teams, standardizing diagnostic and treatment protocols, and ensuring equitable access to advanced diagnostics and treatments. Conclusions: The CARABELA-ATTR initiative provides a framework that emphasizes multidisciplinary coordination, diagnostic and treatment protocols, continuous education for healthcare professionals and patients, and equitable access to resources, aiming to improve patient outcomes and quality of life.